NCT01015235View on ClinicalTrials.gov

Safety and Efficacy Study of KAI-1678 to Treat Subjects With Postoperative Pain

PHASE2CompletedINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

December 31, 2008

Primary Completion Date

February 28, 2010

Study Completion Date

February 28, 2010

Conditions
Pain, Postoperative
Interventions
DRUG

Placebo

Subcutaneous infusion-once over 4 hours

DRUG

KAI-1678

Subcutaneous infusion-once over 4 hours

DRUG

Ketorolac Tromethamine

Active comparator, IV infusion, once

Trial Locations (1)

Unknown

Hamilton

Sponsors
All Listed Sponsors
collaborator

Trident Clinical Research Pty Ltd

INDUSTRY

lead

KAI Pharmaceuticals

INDUSTRY

NCT01015235 - Safety and Efficacy Study of KAI-1678 to Treat Subjects With Postoperative Pain | Biotech Hunter | Biotech Hunter